This menu provides the list of EV proteins identified by high-throughput analyses.

Search:
Superdomain: All Prokaryote Eukaryote
Filter datasets:
  - "Sample type" indicates the source from which EVs originated (e.g. B cell, serum).
  - "Sample status" indicates the condition of the source from which EVs originated (e.g. Normal, miR-146a-treated, Patients of hernia).
Number of molecules in one page:

The downloaded CSV file is not exactly the same as the displayed table. Opening CSV file with Excel can impair its content.

Protein name UniProt accession Publication Orthologous group Identification count
All / Prokaryote / Eukaryote
D-3-phosphoglycerate dehydrogenase (3-PGDH) (EC 1.1.1.95) (A10)Q61753Proteomic characterization of thymocyte-derived microvesicles and apoptotic bodies in BALB/c mice.
J Proteomics. 2011 Sep 6;74(10):2025-33. doi: 10.1016/j.jprot.2011.05.023. Epub 2011 May 19.
COG0111316 / 20 / 296
D-3-phosphoglycerate dehydrogenase (3-PGDH) (EC 1.1.1.95) (A10)Q61753Exosomes mediate stromal mobilization of autocrine Wnt-PCP signaling in breast cancer cell migration.
Cell. 2012 Dec 21;151(7):1542-56. doi: 10.1016/j.cell.2012.11.024.
COG0111316 / 20 / 296
D-3-phosphoglycerate dehydrogenase (3-PGDH) (EC 1.1.1.95) (A10)Q61753Immunomodulatory impact of leishmania-induced macrophage exosomes: a comparative proteomic and functional analysis.
PLoS Negl Trop Dis. 2013 May 2;7(5):e2185. doi: 10.1371/journal.pntd.0002185. Print 2013.
COG0111316 / 20 / 296
D-3-phosphoglycerate dehydrogenase (3-PGDH) (EC 1.1.1.95) (A10)Q61753Immunomodulatory impact of leishmania-induced macrophage exosomes: a comparative proteomic and functional analysis.
PLoS Negl Trop Dis. 2013 May 2;7(5):e2185. doi: 10.1371/journal.pntd.0002185. Print 2013.
COG0111316 / 20 / 296
D-3-phosphoglycerate dehydrogenase (3-PGDH) (EC 1.1.1.95) (A10)Q61753Immunomodulatory impact of leishmania-induced macrophage exosomes: a comparative proteomic and functional analysis.
PLoS Negl Trop Dis. 2013 May 2;7(5):e2185. doi: 10.1371/journal.pntd.0002185. Print 2013.
COG0111316 / 20 / 296
D-3-phosphoglycerate dehydrogenase (3-PGDH) (EC 1.1.1.95) (A10)Q61753Exosomes from myeloid-derived suppressor cells carry biologically active proteins.
J Proteome Res. 2014 Feb 7;13(2):836-43. doi: 10.1021/pr400879c. Epub 2013 Dec 13.
COG0111316 / 20 / 296
D-3-phosphoglycerate dehydrogenase (3-PGDH) (EC 1.1.1.95) (A10)Q61753Lipid synthesis is promoted by hypoxic adipocyte-derived exosomes in 3T3-L1 cells.
Biochem Biophys Res Commun. 2014 Mar 7;445(2):327-33. doi: 10.1016/j.bbrc.2014.01.183. Epub 2014 Feb 7.
COG0111316 / 20 / 296
D-3-phosphoglycerate dehydrogenase (3-PGDH) (EC 1.1.1.95) (A10)Q61753Lipid synthesis is promoted by hypoxic adipocyte-derived exosomes in 3T3-L1 cells.
Biochem Biophys Res Commun. 2014 Mar 7;445(2):327-33. doi: 10.1016/j.bbrc.2014.01.183. Epub 2014 Feb 7.
COG0111316 / 20 / 296
D-3-phosphoglycerate dehydrogenase (3-PGDH) (EC 1.1.1.95) (A10)Q61753Extracellular Vesicles from Neural Stem Cells Transfer IFN-gamma via Ifngr1 to Activate Stat1 Signaling in Target Cells.
Mol Cell. 2014 Sep 16. pii: S1097-2765(14)00675-3. doi: 10.1016/j.molcel.2014.08.020.
COG0111316 / 20 / 296
D-3-phosphoglycerate dehydrogenase (3-PGDH) (EC 1.1.1.95) (A10)Q61753Extracellular Vesicles from Neural Stem Cells Transfer IFN-gamma via Ifngr1 to Activate Stat1 Signaling in Target Cells.
Mol Cell. 2014 Sep 16. pii: S1097-2765(14)00675-3. doi: 10.1016/j.molcel.2014.08.020.
COG0111316 / 20 / 296
D-3-phosphoglycerate dehydrogenase (3-PGDH) (EC 1.1.1.95) (A10)Q61753Membrane microvesicles as mediators for melanoma-fibroblasts communication: Roles of the VCAM-1/VLA-4 axis and the ERK1/2 signal pathway.
Cancer Lett. 2015 Feb 4. pii: S0304-3835(15)00066-X. doi: 10.1016/j.canlet.2015.01.032.
COG0111316 / 20 / 296
D-3-phosphoglycerate dehydrogenase (3-PGDH) (EC 1.1.1.95) (A10)Q61753Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver.
Nat Cell Biol. 2015 May 18. doi: 10.1038/ncb3169.
COG0111316 / 20 / 296
D-3-phosphoglycerate dehydrogenase (3-PGDH) (EC 1.1.1.95) (A10)Q61753A comprehensive proteomics analysis reveals a secretory path- and status-dependent signature of exosomes released from tumor associated macrophages.
J Proteome Res. 2015 Aug 27.
COG0111316 / 20 / 296
D-3-phosphoglycerate dehydrogenase (3-PGDH) (EC 1.1.1.95) (A10)Q61753A comprehensive proteomics analysis reveals a secretory path- and status-dependent signature of exosomes released from tumor associated macrophages.
J Proteome Res. 2015 Aug 27.
COG0111316 / 20 / 296
D-3-phosphoglycerate dehydrogenase (3-PGDH) (EC 1.1.1.95) (A10)Q61753Cells release subpopulations of exosomes with distinct molecular and biological properties.
Sci Rep. 2016 Mar 2;6:22519. doi: 10.1038/srep22519.
COG0111316 / 20 / 296
D-3-phosphoglycerate dehydrogenase (3-PGDH) (EC 1.1.1.95) (A10)Q61753Cells release subpopulations of exosomes with distinct molecular and biological properties.
Sci Rep. 2016 Mar 2;6:22519. doi: 10.1038/srep22519.
COG0111316 / 20 / 296
D-3-phosphoglycerate dehydrogenase (3-PGDH) (EC 1.1.1.95) (A10)Q61753Cells release subpopulations of exosomes with distinct molecular and biological properties.
Sci Rep. 2016 Mar 2;6:22519. doi: 10.1038/srep22519.
COG0111316 / 20 / 296
D-3-phosphoglycerate dehydrogenase (3-PGDH) (EC 1.1.1.95) (A10)Q61753Adipocyte exosomes promote melanoma aggressiveness through fatty acid oxidation: a novel mechanism linking obesity and cancer.
Cancer Res. 2016 May 23. pii: canres.0651.2016.
COG0111316 / 20 / 296
D-3-phosphoglycerate dehydrogenase (3-PGDH) (EC 1.1.1.95) (A10)Q61753Microvesicles provide a mechanism for intercellular communication by embryonic stem cells during embryo implantation.
Nat Commun. 2016 Jun 15;7:11958. doi: 10.1038/ncomms11958.
COG0111316 / 20 / 296
D-3-phosphoglycerate dehydrogenase (3-PGDH) (EC 1.1.1.95) (A10)Q61753Procoagulant and immunogenic properties of melanoma exosomes, microvesicles and apoptotic vesicles.
Oncotarget. 2016 Jul 22. doi: 10.18632/oncotarget.10783.
COG0111316 / 20 / 296
D-3-phosphoglycerate dehydrogenase (3-PGDH) (EC 1.1.1.95) (A10)Q61753Procoagulant and immunogenic properties of melanoma exosomes, microvesicles and apoptotic vesicles.
Oncotarget. 2016 Jul 22. doi: 10.18632/oncotarget.10783.
COG0111316 / 20 / 296
D-3-phosphoglycerate dehydrogenase (3-PGDH) (EC 1.1.1.95) (A10)Q61753Secretome proteomics reveals candidate non-invasive biomarkers of BRCA1 deficiency in breast cancer.
Oncotarget. 2016 Aug 23. doi: 10.18632/oncotarget.11535.
COG0111316 / 20 / 296
D-3-phosphoglycerate dehydrogenase (3-PGDH) (EC 1.1.1.95) (A10)Q61753Secretome proteomics reveals candidate non-invasive biomarkers of BRCA1 deficiency in breast cancer.
Oncotarget. 2016 Aug 23. doi: 10.18632/oncotarget.11535.
COG0111316 / 20 / 296
D-3-phosphoglycerate dehydrogenase (3-PGDH) (EC 1.1.1.95) (A10)Q61753Secretome proteomics reveals candidate non-invasive biomarkers of BRCA1 deficiency in breast cancer.
Oncotarget. 2016 Aug 23. doi: 10.18632/oncotarget.11535.
COG0111316 / 20 / 296
D-3-phosphoglycerate dehydrogenase (3-PGDH) (EC 1.1.1.95) (A10)Q61753Secreted Glioblastoma Nanovesicles Contain Intracellular Signaling Proteins and Active Ras Incorporated in a Farnesylation-dependent Manner.
J Biol Chem. 2016 Dec 1. pii: jbc.M116.747618.
COG0111316 / 20 / 296
D-3-phosphoglycerate dehydrogenase (3-PGDH) (EC 1.1.1.95) (A10)Q61753The Hippo Pathway Kinases LATS1/2 Suppress Cancer Immunity.
Cell. 2016 Dec 1;167(6):1525-1539.e17. doi: 10.1016/j.cell.2016.11.005.
COG0111316 / 20 / 296
D-3-phosphoglycerate dehydrogenase (3-PGDH) (EC 1.1.1.95) (A10)Q61753The Hippo Pathway Kinases LATS1/2 Suppress Cancer Immunity.
Cell. 2016 Dec 1;167(6):1525-1539.e17. doi: 10.1016/j.cell.2016.11.005.
COG0111316 / 20 / 296
D-3-phosphoglycerate dehydrogenase (3-PGDH) (EC 1.1.1.95) (A10)Q61753Astrocyte-shed extracellular vesicles regulate the peripheral leukocyte response to inflammatory brain lesions.
Sci Signal. 2017 Apr 4;10(473). pii: eaai7696. doi: 10.1126/scisignal.aai7696.
COG0111316 / 20 / 296
D-3-phosphoglycerate dehydrogenase (3-PGDH) (EC 1.1.1.95) (A10)Q61753Characterisation of adipocyte-derived extracellular vesicle subtypes identifies distinct protein and lipid signatures for large and small extracellular vesicles.
J Extracell Vesicles. 2017 Apr 10;6(1):1305677. doi: 10.1080/20013078.2017.1305677. eCollection 2017.
COG0111316 / 20 / 296
D-3-phosphoglycerate dehydrogenase (3-PGDH) (EC 1.1.1.95) (A10)Q61753Hypoxia-induced changes in the fibroblast secretome, exosome, and whole-cell proteome using cultured, cardiac-derived cells isolated from neonatal mice.
J Proteome Res. 2017 Jun 22. doi: 10.1021/acs.jproteome.7b00144.
COG0111316 / 20 / 296
D-3-phosphoglycerate dehydrogenase (3-PGDH) (EC 1.1.1.95) (A10)Q61753Hypoxia-induced changes in the fibroblast secretome, exosome, and whole-cell proteome using cultured, cardiac-derived cells isolated from neonatal mice.
J Proteome Res. 2017 Jun 22. doi: 10.1021/acs.jproteome.7b00144.
COG0111316 / 20 / 296
D-3-phosphoglycerate dehydrogenase (3-PGDH) (EC 1.1.1.95) (A10)Q61753Effects of storage temperature on airway exosome integrity for diagnostic and functional analyses.
J Extracell Vesicles. 2017 Aug 13;6(1):1359478. doi: 10.1080/20013078.2017.1359478. eCollection 2017.
COG0111316 / 20 / 296
D-3-phosphoglycerate dehydrogenase (3-PGDH) (EC 1.1.1.95) (A10)Q61753Effects of storage temperature on airway exosome integrity for diagnostic and functional analyses.
J Extracell Vesicles. 2017 Aug 13;6(1):1359478. doi: 10.1080/20013078.2017.1359478. eCollection 2017.
COG0111316 / 20 / 296
D-3-phosphoglycerate dehydrogenase (3-PGDH) (EC 1.1.1.95) (A10)Q61753Effects of storage temperature on airway exosome integrity for diagnostic and functional analyses.
J Extracell Vesicles. 2017 Aug 13;6(1):1359478. doi: 10.1080/20013078.2017.1359478. eCollection 2017.
COG0111316 / 20 / 296
D-3-phosphoglycerate dehydrogenase (3-PGDH) (EC 1.1.1.95) (A10)Q61753Increased Release of Apolipoprotein E in Extracellular Vesicles Following Amyloid-beta Protofibril Exposure of Neuroglial Co-Cultures.
J Alzheimers Dis. 2017 Aug 17. doi: 10.3233/JAD-170278.
COG0111316 / 20 / 296
D-3-phosphoglycerate dehydrogenase (3-PGDH) (EC 1.1.1.95) (A10)Q61753Proteomic profiling of exosomes secreted by breast cancer cells with varying metastatic potential.
Proteomics. 2017 Nov 8. doi: 10.1002/pmic.201600370.
COG0111316 / 20 / 296
D-3-phosphoglycerate dehydrogenase (3-PGDH) (EC 1.1.1.95) (A10)Q61753Proteomic profiling of exosomes secreted by breast cancer cells with varying metastatic potential.
Proteomics. 2017 Nov 8. doi: 10.1002/pmic.201600370.
COG0111316 / 20 / 296
D-3-phosphoglycerate dehydrogenase (3-PGDH) (EC 1.1.1.95) (A10)Q61753Proteomic profiling of exosomes secreted by breast cancer cells with varying metastatic potential.
Proteomics. 2017 Nov 8. doi: 10.1002/pmic.201600370.
COG0111316 / 20 / 296
D-3-phosphoglycerate dehydrogenase (3-PGDH) (EC 1.1.1.95) (A10)Q61753Proteomic profiling of exosomes secreted by breast cancer cells with varying metastatic potential.
Proteomics. 2017 Nov 8. doi: 10.1002/pmic.201600370.
COG0111316 / 20 / 296
D-3-phosphoglycerate dehydrogenase (3-PGDH) (EC 1.1.1.95) (A10)Q61753Differential content of proteins, mRNAs, and miRNAs suggests that MDSC and their exosomes may mediate distinct immune suppressive functions.
J Proteome Res. 2017 Nov 15. doi: 10.1021/acs.jproteome.7b00646.
COG0111316 / 20 / 296
D-3-phosphoglycerate dehydrogenase (3-PGDH) (EC 1.1.1.95) (A10)Q61753Differential content of proteins, mRNAs, and miRNAs suggests that MDSC and their exosomes may mediate distinct immune suppressive functions.
J Proteome Res. 2017 Nov 15. doi: 10.1021/acs.jproteome.7b00646.
COG0111316 / 20 / 296
D-3-phosphoglycerate dehydrogenase (3-PGDH) (EC 1.1.1.95) (A10)Q61753Exosomes as secondary inductive signals involved in kidney organogenesis.
J Extracell Vesicles. 2018 Jan 23;7(1):1422675. doi: 10.1080/20013078.2017.1422675. eCollection 2018.
COG0111316 / 20 / 296
[1]